These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
306 related articles for article (PubMed ID: 25543014)
41. Prognosis after unmanipulated HLA-haploidentical blood and marrow transplantation is correlated to the numbers of KIR ligands in recipients. Zhao XY; Huang XJ; Liu KY; Xu LP; Liu DH Eur J Haematol; 2007 Apr; 78(4):338-46. PubMed ID: 17378893 [TBL] [Abstract][Full Text] [Related]
42. Low incidence of severe acute graft-versus-host disease in children given haematopoietic stem cell transplantation from unrelated donors prospectively matched for HLA class I and II alleles with high-resolution molecular typing. Giebel S; Giorgiani G; Martinetti M; Zecca M; Maccario R; Salvaneschi L; Holowiecki J; Locatelli F Bone Marrow Transplant; 2003 Jun; 31(11):987-93. PubMed ID: 12774049 [TBL] [Abstract][Full Text] [Related]
43. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies. Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687 [TBL] [Abstract][Full Text] [Related]
44. The MICA-129 dimorphism affects NKG2D signaling and outcome of hematopoietic stem cell transplantation. Isernhagen A; Malzahn D; Viktorova E; Elsner L; Monecke S; von Bonin F; Kilisch M; Wermuth JM; Walther N; Balavarca Y; Stahl-Hennig C; Engelke M; Walter L; Bickeböller H; Kube D; Wulf G; Dressel R EMBO Mol Med; 2015 Nov; 7(11):1480-502. PubMed ID: 26483398 [TBL] [Abstract][Full Text] [Related]
45. Impact of vitamin D receptor gene polymorphisms on clinical outcomes of HLA-matched sibling hematopoietic stem cell transplantation. Cho HJ; Shin DY; Kim JH; Bae JY; Lee KH; See CJ; Kim N; Park EK; Ra EK; Lee JE; Hong YC; Kim HK; Park SS; Yoon SS; Lee DS; Han KS; Park MH; Park S; Kim BK; Kim I Clin Transplant; 2012; 26(3):476-83. PubMed ID: 22035017 [TBL] [Abstract][Full Text] [Related]
46. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation. Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686 [TBL] [Abstract][Full Text] [Related]
47. HLA-inferred extended haplotype disparity level is more relevant than the level of HLA mismatch alone for the patients survival and GvHD in T cell-replate hematopoietic stem cell transplantation from unrelated donor. Nowak J; Nestorowicz K; Graczyk-Pol E; Mika-Witkowska R; Rogatko-Koros M; Jaskula E; Koscinska K; Madej S; Tomaszewska A; Nasilowska-Adamska B; Szczepinski A; Halaburda K; Dybko J; Kuliczkowski K; Czerw T; Giebel S; Holowiecki J; Baranska M; Pieczonka A; Wachowiak J; Czyz A; Gil L; Lojko-Dankowska A; Komarnicki M; Bieniaszewska M; Kucharska A; Hellmann A; Gronkowska A; Jedrzejczak WW; Markiewicz M; Koclega A; Kyrcz-Krzemien S; Mielcarek M; Kalwak K; Styczynski J; Wysocki M; Drabko K; Wojcik B; Kowalczyk J; Gozdzik J; Pawliczak D; Gwozdowicz S; Dziopa J; Szlendak U; Witkowska A; Zubala M; Gawron A; Warzocha K; Lange A Hum Immunol; 2018 Jun; 79(6):403-412. PubMed ID: 29605688 [TBL] [Abstract][Full Text] [Related]
48. Protective Effect of HLA-E∗0101∕∗0103 Genotype in Survival of Patients After Allogeneic Hematopoietic Stem Cell Transplant. Mardani Valandani F; Ghorbani-Dalini S; Ramzi M; Aghababa H; Sarshar M; Haghgoo N; Azarpira N Exp Clin Transplant; 2021 Aug; 19(8):849-855. PubMed ID: 32281534 [TBL] [Abstract][Full Text] [Related]
49. Effect of major histocompatibility complex haplotype matching by C4 and MICA genotyping on acute graft versus host disease in unrelated hematopoietic stem cell transplantation. Park Y; Cheong JW; Park MH; Kim MS; Kim JS; Kim HS Hum Immunol; 2016 Feb; 77(2):176-83. PubMed ID: 26602146 [TBL] [Abstract][Full Text] [Related]
50. Role of HLA in hematopoietic SCT. Nowak J Bone Marrow Transplant; 2008 Oct; 42 Suppl 2():S71-6. PubMed ID: 18978750 [TBL] [Abstract][Full Text] [Related]
52. HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for chronic myeloid leukemia: improved outcomes in patients in accelerated phase and blast crisis phase. Xiao-Jun H; Lan-Ping X; Kai-Yan L; Dai-Hong L; Huan C; Wei H; Yu-Hong C; Jing-Zhi W; Yao C; Xiao-Hui Z; Hong-Xia S; Dao-Pei L Ann Med; 2008; 40(6):444-55. PubMed ID: 18608121 [TBL] [Abstract][Full Text] [Related]
53. CTLA-4 polymorphism and clinical outcome post allogeneic hematopoietic stem cell transplantation. Mossallam GI; Samra MA Hum Immunol; 2013 Dec; 74(12):1643-8. PubMed ID: 23973330 [TBL] [Abstract][Full Text] [Related]
54. The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population. Wu GQ; Zhao YM; Lai XY; Luo Y; Tan YM; Shi JM; Li L; Zheng WY; Zhang J; Hu XR; Jin AY; He JS; Xie WZ; Ye XJ; Cai Z; Lin MF; Huang H Bone Marrow Transplant; 2010 Oct; 45(10):1514-21. PubMed ID: 20173784 [TBL] [Abstract][Full Text] [Related]
55. The role of missing killer cell immunoglobulin-like receptor ligands in T cell replete peripheral blood stem cell transplantation from HLA-identical siblings. Clausen J; Kircher B; Auberger J; Schumacher P; Ulmer H; Hetzenauer G; Wolf D; Gastl G; Nachbaur D Biol Blood Marrow Transplant; 2010 Feb; 16(2):273-80. PubMed ID: 19857587 [TBL] [Abstract][Full Text] [Related]
56. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia. Mengarelli A; Iori A; Guglielmi C; Romano A; Cerretti R; Torromeo C; Micozzi A; Fenu S; Laurenti L; Donato V; De Felice L; Arcese W Haematologica; 2002 Jan; 87(1):52-8. PubMed ID: 11801465 [TBL] [Abstract][Full Text] [Related]
57. Synergistic effect of major histocompatibility complex class I-related chain a and human leukocyte antigen-DPB1 mismatches in association with acute graft-versus-host disease after unrelated donor hematopoietic stem cell transplantation. Askar M; Sun Y; Rybicki L; Zhang A; Thomas D; Kalaycio M; Pohlman B; Dean R; Duong H; Hanna R; Maciejewski J; Majhail NS; Bolwell B; Sobecks R Biol Blood Marrow Transplant; 2014 Nov; 20(11):1835-40. PubMed ID: 25064744 [TBL] [Abstract][Full Text] [Related]
58. Donor selection for killer immunoglobulin-like receptors B haplotype of the centromeric motifs can improve the outcome after HLA-identical sibling hematopoietic stem cell transplantation. Zhou H; Bao X; Wu X; Tang X; Wang M; Wu D; He J Biol Blood Marrow Transplant; 2014 Jan; 20(1):98-105. PubMed ID: 24516895 [TBL] [Abstract][Full Text] [Related]
59. Immune reconstitution following myeloablative allogeneic hematopoietic stem cell transplantation: the impact of expanding CD28negative CD8+ T cells on relapse. Yakoub-Agha I; Saule P; Magro L; Cracco P; Duhamel A; Coiteux V; Bruno B; Dufossé F; Jouet JP; Dessaint JP; Labalette M Biol Blood Marrow Transplant; 2009 Apr; 15(4):496-504. PubMed ID: 19285638 [TBL] [Abstract][Full Text] [Related]
60. Related HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion: observations of a single Chinese center. Huang X; Liu D Clin Transpl; 2011; ():237-45. PubMed ID: 22755417 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]